Literature DB >> 19111749

Crystal structure of rhizavidin: insights into the enigmatic high-affinity interaction of an innate biotin-binding protein dimer.

Amit Meir1, Satu H Helppolainen, Erez Podoly, Henri R Nordlund, Vesa P Hytönen, Juha A Määttä, Meir Wilchek, Edward A Bayer, Markku S Kulomaa, Oded Livnah.   

Abstract

Rhizavidin, from the proteobacterium Rhizobium etli, exhibits high affinity towards biotin but maintains an inherent dimeric quaternary structure and thus, differs from all other known tetrameric avidins. Rhizavidin also differs from the other avidins, since it lacks the characteristic tryptophan residue positioned in the L7,8 loop that plays a crucial role in high-affinity binding and oligomeric stability of the tetrameric avidins. The question is, therefore, how does the dimer exist and how is the high biotin-binding affinity retained? For this purpose, the crystal structures of apo- and biotin-complexed rhizavidin were determined. The structures reveal that the rhizavidin monomer exhibits a topology similar to those of other members of the avidin family, that is, eight antiparallel beta-strands that form the conventional avidin beta-barrel. The quaternary structure comprises the sandwich-like dimer, in which the extensive 1-4 intermonomer interface is intact, but the 1-2 and 1-3 interfaces are nonexistent. Consequently, the biotin-binding site is partially accessible, due to the lack of the tryptophan "lid" that distinguishes the tetrameric structures. In rhizavidin, a disulfide bridge connecting the L3,4 and L5,6 loops restrains the L3,4 loop conformation, leaving the binding-site residues essentially unchanged upon biotin binding. Our study suggests that in addition to the characteristic hydrogen bonding and hydrophobic interactions, the preformed architecture of the binding site and consequent shape complementarity play a decisive role in the high-affinity biotin binding of rhizavidin. The structural description of a novel dimeric avidin-like molecule will greatly contribute to the design of improved and unique avidin derivatives for diversifying the capabilities of avidin-biotin technology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19111749     DOI: 10.1016/j.jmb.2008.11.061

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  Structural adaptation of a thermostable biotin-binding protein in a psychrophilic environment.

Authors:  Amit Meir; Edward A Bayer; Oded Livnah
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

2.  Challenging semi-bootstrapping molecular-replacement strategy reveals intriguing crystal packing of rhizavidin.

Authors:  Amit Meir; Oded Livnah
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-03-26

3.  Structural analysis of Bacillus pumilus phenolic acid decarboxylase, a lipocalin-fold enzyme.

Authors:  Allan Matte; Stephan Grosse; Hélène Bergeron; Kofi Abokitse; Peter C K Lau
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-10-27

Review 4.  The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.

Authors:  Akshay Jain; Kun Cheng
Journal:  J Control Release       Date:  2016-11-16       Impact factor: 9.776

Review 5.  New Technologies Bloom Together for Bettering Cancer Drug Conjugates.

Authors:  Yiming Jin; Shahab Edalatian Zakeri; Raman Bahal; Andrew J Wiemer
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

6.  Effect of cargo size and shape on the transport efficiency of the bacterial Tat translocase.

Authors:  Neal Whitaker; Umesh Bageshwar; Siegfried M Musser
Journal:  FEBS Lett       Date:  2013-02-16       Impact factor: 4.124

7.  The highly dynamic oligomeric structure of bradavidin II is unique among avidin proteins.

Authors:  Jenni Leppiniemi; Amit Meir; Niklas Kähkönen; Sampo Kukkurainen; Juha A Määttä; Markus Ojanen; Janne Jänis; Markku S Kulomaa; Oded Livnah; Vesa P Hytönen
Journal:  Protein Sci       Date:  2013-06-06       Impact factor: 6.725

8.  How the biotin-streptavidin interaction was made even stronger: investigation via crystallography and a chimaeric tetramer.

Authors:  Claire E Chivers; Apurba L Koner; Edward D Lowe; Mark Howarth
Journal:  Biochem J       Date:  2011-04-01       Impact factor: 3.857

9.  Conjugation of biotin-coated luminescent quantum dots with single domain antibody-rhizavidin fusions.

Authors:  Jinny L Liu; Scott A Walper; Kendrick B Turner; Audrey Brozozog Lee; Igor L Medintz; Kimihiro Susumu; Eunkeu Oh; Dan Zabetakis; Ellen R Goldman; George P Anderson
Journal:  Biotechnol Rep (Amst)       Date:  2016-03-03

10.  Structure of bradavidin-C-terminal residues act as intrinsic ligands.

Authors:  Jenni Leppiniemi; Toni Grönroos; Juha A E Määttä; Mark S Johnson; Markku S Kulomaa; Vesa P Hytönen; Tomi T Airenne
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.